Mary Patricia Mullen, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 33 | 2023 | 1537 | 4.350 |
Why?
|
| Vein of Galen Malformations | 1 | 2023 | 53 | 0.850 |
Why?
|
| Family Relations | 2 | 2014 | 321 | 0.810 |
Why?
|
| Pulmonary Artery | 6 | 2021 | 1912 | 0.810 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2022 | 263 | 0.700 |
Why?
|
| Bronchopulmonary Dysplasia | 5 | 2022 | 306 | 0.690 |
Why?
|
| Vascular Resistance | 2 | 2019 | 936 | 0.580 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2022 | 581 | 0.560 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2019 | 488 | 0.550 |
Why?
|
| Lung Transplantation | 4 | 2022 | 1153 | 0.550 |
Why?
|
| Heart Defects, Congenital | 8 | 2022 | 4584 | 0.490 |
Why?
|
| Scurvy | 1 | 2013 | 29 | 0.470 |
Why?
|
| Adaptation, Psychological | 2 | 2014 | 2576 | 0.450 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2013 | 53 | 0.430 |
Why?
|
| Infant, Premature, Diseases | 3 | 2022 | 706 | 0.430 |
Why?
|
| Chylothorax | 1 | 2013 | 84 | 0.420 |
Why?
|
| Pulmonary Wedge Pressure | 2 | 2022 | 264 | 0.410 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 2 | 2012 | 139 | 0.390 |
Why?
|
| Vasodilator Agents | 5 | 2022 | 977 | 0.390 |
Why?
|
| Parents | 2 | 2014 | 3407 | 0.360 |
Why?
|
| Infant | 23 | 2023 | 35136 | 0.360 |
Why?
|
| Lung Abscess | 1 | 2010 | 42 | 0.360 |
Why?
|
| Infant, Newborn | 20 | 2023 | 25625 | 0.340 |
Why?
|
| Epoprostenol | 2 | 2020 | 254 | 0.330 |
Why?
|
| Pulmonary Atresia | 1 | 2010 | 160 | 0.330 |
Why?
|
| T-Box Domain Proteins | 2 | 2023 | 471 | 0.330 |
Why?
|
| Child | 29 | 2023 | 77709 | 0.320 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 615 | 0.320 |
Why?
|
| Angioplasty, Balloon | 1 | 2013 | 653 | 0.320 |
Why?
|
| Activin Receptors, Type II | 1 | 2009 | 127 | 0.320 |
Why?
|
| Angiography | 1 | 2011 | 1639 | 0.260 |
Why?
|
| Abnormalities, Multiple | 2 | 2010 | 1416 | 0.250 |
Why?
|
| Tetralogy of Fallot | 1 | 2010 | 623 | 0.250 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2010 | 3537 | 0.240 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 1343 | 0.240 |
Why?
|
| Down Syndrome | 2 | 2022 | 880 | 0.230 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2015 | 1354 | 0.220 |
Why?
|
| Quality of Life | 2 | 2014 | 12804 | 0.210 |
Why?
|
| Registries | 5 | 2022 | 8089 | 0.210 |
Why?
|
| Nitric Oxide | 3 | 2023 | 2132 | 0.210 |
Why?
|
| Child, Preschool | 17 | 2023 | 41006 | 0.200 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2023 | 214 | 0.200 |
Why?
|
| Heparin | 1 | 2008 | 1637 | 0.190 |
Why?
|
| Prostaglandins | 1 | 2022 | 405 | 0.190 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2020 | 63 | 0.180 |
Why?
|
| Thrombocytopenia | 1 | 2008 | 1179 | 0.180 |
Why?
|
| Lung Diseases | 1 | 2010 | 1886 | 0.180 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2019 | 116 | 0.180 |
Why?
|
| Actigraphy | 1 | 2023 | 488 | 0.170 |
Why?
|
| Current Procedural Terminology | 1 | 2020 | 92 | 0.170 |
Why?
|
| Humans | 54 | 2023 | 744343 | 0.170 |
Why?
|
| Veins | 1 | 2023 | 770 | 0.160 |
Why?
|
| Pediatric Nursing | 1 | 2019 | 103 | 0.160 |
Why?
|
| Retrospective Studies | 17 | 2023 | 77449 | 0.160 |
Why?
|
| End Stage Liver Disease | 1 | 2022 | 314 | 0.160 |
Why?
|
| Ventricular Function, Right | 1 | 2022 | 591 | 0.160 |
Why?
|
| GTPase-Activating Proteins | 1 | 2021 | 498 | 0.160 |
Why?
|
| Electronic Health Records | 3 | 2020 | 4468 | 0.150 |
Why?
|
| Heart Ventricles | 2 | 2022 | 3821 | 0.150 |
Why?
|
| Antihypertensive Agents | 2 | 2020 | 2046 | 0.140 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2015 | 19 | 0.140 |
Why?
|
| Pulmonary Circulation | 1 | 2019 | 739 | 0.140 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2015 | 66 | 0.130 |
Why?
|
| Gastroesophageal Reflux | 1 | 2022 | 782 | 0.130 |
Why?
|
| Semantics | 1 | 2019 | 584 | 0.130 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2019 | 500 | 0.130 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2017 | 406 | 0.120 |
Why?
|
| Infusions, Intravenous | 1 | 2019 | 2274 | 0.120 |
Why?
|
| Iloprost | 1 | 2013 | 29 | 0.110 |
Why?
|
| Male | 27 | 2023 | 350118 | 0.110 |
Why?
|
| Safety Management | 1 | 2019 | 783 | 0.110 |
Why?
|
| Clinical Protocols | 1 | 2019 | 1462 | 0.110 |
Why?
|
| Anticoagulants | 1 | 2008 | 4599 | 0.110 |
Why?
|
| Medication Errors | 1 | 2019 | 798 | 0.110 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2021 | 808 | 0.110 |
Why?
|
| Heart Valve Diseases | 1 | 2020 | 1073 | 0.110 |
Why?
|
| Data Mining | 1 | 2017 | 537 | 0.100 |
Why?
|
| Female | 27 | 2023 | 380194 | 0.100 |
Why?
|
| Heart Arrest | 1 | 2022 | 1470 | 0.100 |
Why?
|
| Psychology | 1 | 2014 | 356 | 0.100 |
Why?
|
| Adolescent | 14 | 2022 | 85781 | 0.100 |
Why?
|
| Natural Language Processing | 1 | 2020 | 1041 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2019 | 2751 | 0.100 |
Why?
|
| Phenotype | 5 | 2023 | 16365 | 0.100 |
Why?
|
| Liver Transplantation | 1 | 2022 | 2119 | 0.100 |
Why?
|
| Tropomyosin | 1 | 1991 | 102 | 0.100 |
Why?
|
| Pediatrics | 2 | 2019 | 3475 | 0.090 |
Why?
|
| Sulfones | 1 | 2012 | 437 | 0.090 |
Why?
|
| Disease Management | 2 | 2017 | 2459 | 0.090 |
Why?
|
| Bayes Theorem | 1 | 2017 | 2309 | 0.080 |
Why?
|
| Pedigree | 3 | 2021 | 4644 | 0.080 |
Why?
|
| Lung | 4 | 2022 | 9856 | 0.080 |
Why?
|
| Treatment Outcome | 7 | 2020 | 63114 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2019 | 2684 | 0.080 |
Why?
|
| Severity of Illness Index | 4 | 2017 | 15540 | 0.080 |
Why?
|
| Sampling Studies | 1 | 2010 | 623 | 0.080 |
Why?
|
| Follow-Up Studies | 5 | 2019 | 39050 | 0.080 |
Why?
|
| Insurance, Health | 2 | 2020 | 2494 | 0.080 |
Why?
|
| Platelet Factor 4 | 1 | 2008 | 129 | 0.080 |
Why?
|
| Prevalence | 2 | 2022 | 15226 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 17446 | 0.070 |
Why?
|
| Surface-Active Agents | 1 | 2007 | 159 | 0.070 |
Why?
|
| Respiratory Tract Diseases | 1 | 2013 | 722 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2018 | 2073 | 0.070 |
Why?
|
| Genes | 1 | 1991 | 1893 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2013 | 2971 | 0.070 |
Why?
|
| Fontan Procedure | 1 | 2013 | 778 | 0.070 |
Why?
|
| Quantitative Trait Loci | 1 | 2014 | 2019 | 0.070 |
Why?
|
| Exercise | 3 | 2023 | 5615 | 0.070 |
Why?
|
| Aorta, Thoracic | 1 | 2013 | 1082 | 0.070 |
Why?
|
| Hemodynamics | 2 | 2022 | 4199 | 0.070 |
Why?
|
| RNA Splicing | 1 | 1991 | 907 | 0.070 |
Why?
|
| Infant, Premature | 3 | 2022 | 2044 | 0.070 |
Why?
|
| Postoperative Complications | 3 | 2020 | 15295 | 0.070 |
Why?
|
| Reoperation | 2 | 2020 | 4201 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 2703 | 0.060 |
Why?
|
| Exons | 1 | 1991 | 2437 | 0.060 |
Why?
|
| Immunoglobulins | 1 | 2008 | 881 | 0.060 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2005 | 250 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2019 | 10252 | 0.060 |
Why?
|
| Drainage | 1 | 2010 | 1142 | 0.060 |
Why?
|
| Young Adult | 7 | 2019 | 56430 | 0.060 |
Why?
|
| Antibody Formation | 1 | 2008 | 1402 | 0.060 |
Why?
|
| Neural Crest | 1 | 2005 | 275 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2023 | 12208 | 0.060 |
Why?
|
| Echocardiography | 2 | 2018 | 5102 | 0.050 |
Why?
|
| Piperazines | 1 | 2012 | 2488 | 0.050 |
Why?
|
| Caregivers | 1 | 2014 | 2094 | 0.050 |
Why?
|
| Algorithms | 4 | 2019 | 13881 | 0.050 |
Why?
|
| Sulfonamides | 1 | 2011 | 1938 | 0.050 |
Why?
|
| Administration, Inhalation | 2 | 2015 | 1105 | 0.050 |
Why?
|
| Endostatins | 1 | 2021 | 174 | 0.050 |
Why?
|
| Exercise Test | 2 | 2023 | 2074 | 0.050 |
Why?
|
| Hypertension | 1 | 2021 | 8480 | 0.050 |
Why?
|
| Feeding Behavior | 1 | 2013 | 3188 | 0.050 |
Why?
|
| Stents | 1 | 2013 | 3280 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2014 | 8324 | 0.050 |
Why?
|
| Lymphocytosis | 1 | 2021 | 119 | 0.050 |
Why?
|
| Altitude | 1 | 2021 | 161 | 0.050 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2021 | 262 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2021 | 21746 | 0.050 |
Why?
|
| Health Personnel | 1 | 2014 | 3218 | 0.050 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 4186 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2013 | 9849 | 0.050 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2021 | 241 | 0.050 |
Why?
|
| Leukocytosis | 1 | 2021 | 247 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2023 | 53288 | 0.040 |
Why?
|
| Galectin 3 | 1 | 2021 | 227 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2020 | 6459 | 0.040 |
Why?
|
| Acute Disease | 1 | 2010 | 7149 | 0.040 |
Why?
|
| Neoplasms, Experimental | 1 | 1984 | 1276 | 0.040 |
Why?
|
| Education, Nursing, Continuing | 1 | 2019 | 75 | 0.040 |
Why?
|
| Myosin Heavy Chains | 1 | 2000 | 414 | 0.040 |
Why?
|
| DNA Copy Number Variations | 2 | 2019 | 1941 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2014 | 4245 | 0.040 |
Why?
|
| Tracheostomy | 1 | 2022 | 401 | 0.040 |
Why?
|
| Biopsy | 1 | 2010 | 6756 | 0.040 |
Why?
|
| Sarcomeres | 1 | 2000 | 374 | 0.040 |
Why?
|
| Risk | 1 | 2010 | 9687 | 0.040 |
Why?
|
| Postnatal Care | 1 | 2019 | 236 | 0.040 |
Why?
|
| Respiratory Function Tests | 1 | 2021 | 1616 | 0.040 |
Why?
|
| Classification | 1 | 2017 | 129 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2010 | 20129 | 0.040 |
Why?
|
| Adult | 8 | 2019 | 214055 | 0.040 |
Why?
|
| Homozygote | 1 | 2021 | 1785 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2009 | 3444 | 0.030 |
Why?
|
| Troponin T | 1 | 2000 | 754 | 0.030 |
Why?
|
| North America | 1 | 2019 | 1249 | 0.030 |
Why?
|
| Standard of Care | 1 | 2019 | 564 | 0.030 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2015 | 80 | 0.030 |
Why?
|
| Prognosis | 2 | 2017 | 29063 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2010 | 9146 | 0.030 |
Why?
|
| Genes, Dominant | 2 | 2012 | 880 | 0.030 |
Why?
|
| Survival Rate | 2 | 2020 | 12788 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 12959 | 0.030 |
Why?
|
| Ventilator-Induced Lung Injury | 1 | 2015 | 122 | 0.030 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2000 | 851 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 8642 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2021 | 1676 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2017 | 23338 | 0.030 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2021 | 1573 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2014 | 496 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2022 | 40561 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2022 | 2240 | 0.030 |
Why?
|
| Heterozygote | 1 | 2019 | 2804 | 0.030 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2015 | 367 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2020 | 3913 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2020 | 4933 | 0.030 |
Why?
|
| Gestational Age | 1 | 2021 | 3493 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2019 | 1092 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 2015 | 600 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2021 | 3200 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 7181 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 7279 | 0.020 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2012 | 192 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 40075 | 0.020 |
Why?
|
| Chromosome Mapping | 2 | 2014 | 4740 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1991 | 427 | 0.020 |
Why?
|
| Cell-Free System | 1 | 1991 | 344 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1991 | 878 | 0.020 |
Why?
|
| Fetus | 1 | 2018 | 1880 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2023 | 3313 | 0.020 |
Why?
|
| Critical Illness | 1 | 2023 | 2670 | 0.020 |
Why?
|
| Forecasting | 1 | 2019 | 2951 | 0.020 |
Why?
|
| United States | 4 | 2020 | 69872 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2013 | 987 | 0.020 |
Why?
|
| Purines | 1 | 2012 | 594 | 0.020 |
Why?
|
| Hospitals | 1 | 2023 | 3952 | 0.020 |
Why?
|
| Cardiovascular Agents | 1 | 2015 | 850 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2021 | 5097 | 0.020 |
Why?
|
| Heart Failure | 1 | 2013 | 10900 | 0.020 |
Why?
|
| Disease Progression | 2 | 2017 | 13284 | 0.020 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2012 | 430 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2022 | 5317 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2022 | 3114 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2014 | 1813 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2014 | 3588 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2013 | 2029 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 2012 | 956 | 0.020 |
Why?
|
| Middle Aged | 4 | 2014 | 213383 | 0.020 |
Why?
|
| Curriculum | 1 | 2019 | 3605 | 0.020 |
Why?
|
| Mice, Hairless | 1 | 1984 | 41 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2005 | 295 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2012 | 1584 | 0.020 |
Why?
|
| Animals | 4 | 2023 | 168757 | 0.020 |
Why?
|
| PUVA Therapy | 1 | 1984 | 98 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2015 | 2569 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 6544 | 0.010 |
Why?
|
| Vascular Surgical Procedures | 1 | 2013 | 1475 | 0.010 |
Why?
|
| Models, Biological | 1 | 2020 | 9583 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 2000 | 18111 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 13989 | 0.010 |
Why?
|
| Age Factors | 1 | 2020 | 18370 | 0.010 |
Why?
|
| Aged | 2 | 2014 | 163280 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 35421 | 0.010 |
Why?
|
| Comorbidity | 1 | 2017 | 10388 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 14722 | 0.010 |
Why?
|
| Nonmuscle Myosin Type IIB | 1 | 2000 | 20 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15076 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 3507 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 19905 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2000 | 299 | 0.010 |
Why?
|
| Base Sequence | 1 | 1991 | 12797 | 0.010 |
Why?
|
| Syndrome | 1 | 2005 | 3251 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2012 | 3479 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2013 | 12026 | 0.010 |
Why?
|
| Pyrimidines | 1 | 1991 | 2942 | 0.010 |
Why?
|
| Mice | 2 | 2021 | 81183 | 0.010 |
Why?
|
| Pregnancy | 1 | 2019 | 29144 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1991 | 7722 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2000 | 1585 | 0.010 |
Why?
|
| Mutation | 1 | 2019 | 29786 | 0.010 |
Why?
|
| Rats | 1 | 1991 | 24260 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2000 | 2564 | 0.010 |
Why?
|
| DNA | 1 | 1984 | 7301 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2000 | 13815 | 0.010 |
Why?
|
| Myocardium | 1 | 2000 | 4776 | 0.000 |
Why?
|
| Ultrasonography | 1 | 2000 | 5985 | 0.000 |
Why?
|